ABX464
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for ABX464, covering 2016-04-08 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis [Phase 2]